Suri Anish
SEC CIK 1739130 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | Pres, CSO | 135.6K | $11.0K | $750.4K | 11 | 2021-09-23 | 2023-08-25 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Suri Anish made no open-market trades at CUE in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-29 | 2023-08-25 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | P - Purchase | $2.76 | +4,000 | 135.6K | +3% | +$11.0K | |
| D | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | F - Tax | $4.88 | -7,068 | 103.6K | -6% | -$34.5K |
| D | 2022-04-04 | 2022-03-31 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | M - OptEx | — | +16.7K | 110.7K | +18% | — |
| D | 2021-11-17 | 2021-11-15 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres, CSO | S - Sale+OE | $18.05 | -8,000 | 94.0K | -8% | -$144.4K |
| D | 2021-11-17 | 2021-11-15 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres, CSO | M - OptEx | $8.26 | +8,000 | 102.0K | +9% | +$66.1K |
| D | 2021-11-15 | 2021-11-11 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres, CSO | S - Sale+OE | $15.07 | -20.0K | 94.0K | -18% | -$301.4K |
| D | 2021-11-15 | 2021-11-11 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres, CSO | M - OptEx | $6.42 | +20.0K | 114.0K | +21% | +$128.4K |
| D | 2021-10-08 | 2021-10-03 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | M - OptEx | — | +33.3K | 108.2K | +45% | — |
| D | 2021-10-08 | 2021-10-06 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | F - Tax | $12.97 | -14.1K | 94.0K | -13% | -$183.3K |
| D | 2021-09-27 | 2021-09-23 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | M - OptEx | $6.42 | +20.0K | 94.8K | +27% | +$128.4K |
| D | 2021-09-27 | 2021-09-23 | CUE | Cue Biopharma, Inc. | Suri Anish | Pres AND CSO | S - Sale+OE | $15.23 | -20.0K | 74.8K | -21% | -$304.6K |
Purchase Sale Sale after option exercise All abbreviations